Acurx Pharmaceuticals

United States
Woodland Park, New Jersey, United States

Company profile

Acurx Pharmaceuticals company profile

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).

Business identity

Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2017-01-01

Headquarters

Headquarters
Woodland Park, New Jersey, United States
Postal code
10603
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
6
Total equity funding
$11.7M
Last funding
Grant / 2025-11-18
Last equity funding
Post Ipo Equity / $1.4M
Investors
1
Lead investors
1
Founders
2
Articles
139
Exited on
2021-06-25

Categories and groups

Founders and investors

Founders

David LuciRobert G. Shawah

Lead investors

Health Holland

Investors

Health Holland

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.